Holen Sie sich die Stockscreener-App
3.675
5.91%
0.205
Schlusskurs vom Vortag:
$3.47
Offen:
$3.43
24-Stunden-Volumen:
838.11K
Relative Volume:
0.32
Marktkapitalisierung:
$314.54M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-36.95M
KGV:
-4.375
EPS:
-0.84
Netto-Cashflow:
$-33.46M
1W Leistung:
+4.11%
1M Leistung:
-3.29%
6M Leistung:
+50.00%
1J Leistung:
-39.56%
1-Tages-Spanne:
$3.36
$3.745
1-Wochen-Bereich:
$3.12
$3.745
52-Wochen-Spanne:
$1.61
$6.91
Larimar Therapeutics Inc Stock (LRMR) Company Profile
Firmenname
Larimar Therapeutics Inc
Sektor
Branche
Telefon
844-511-9056
Adresse
THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA
Vergleichen Sie LRMR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRMR
Larimar Therapeutics Inc
|
3.675 | 297.00M | 0 | -36.95M | -33.46M | -0.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Larimar Therapeutics Inc Stock (LRMR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-29 | Eingeleitet | Truist | Buy |
| 2024-10-16 | Eingeleitet | Oppenheimer | Outperform |
| 2024-10-03 | Eingeleitet | Wedbush | Outperform |
| 2024-10-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-09-04 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-03 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-17 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-10-19 | Eingeleitet | Guggenheim | Buy |
| 2022-02-15 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-02-10 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-02-01 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Larimar Therapeutics Inc Aktie (LRMR) Neueste Nachrichten
Can Larimar Therapeutics Inc. stock sustain market leadership2025 Winners & Losers & Weekly Return Optimization Alerts - Newser
How geopolitical risks impact Larimar Therapeutics Inc. (ZA71) stockMarket Rally & AI Enhanced Execution Alerts - Newser
Top 3 Health Care Stocks That May Rocket Higher In December - Benzinga
How Larimar Therapeutics Inc. (ZA71) stock behaves in tightening cyclesAnalyst Upgrade & Proven Capital Preservation Methods - Newser
Will Larimar Therapeutics Inc. (ZA71) stock recover faster than industry2025 Big Picture & Free AI Powered Buy and Sell Recommendations - Newser
Will Larimar Therapeutics Inc. (ZA71) stock profit from automation wave2025 Trade Ideas & Weekly Watchlist for Hot Stocks - Newser
Why Larimar Therapeutics Inc. (ZA71) stock stays undervaluedWeekly Trend Recap & Comprehensive Market Scan Insights - Newser
Bronstein, Gewirtz & Grossman, LLC Encourages Larimar Therapeutic - The National Law Review
Is Larimar Therapeutics Inc a good long term investmentStock Rotation Strategies & High Return Capital Strategies - earlytimes.in
Short Covering May Lift Piccadily Sugar Allied Industries Limited in Near TermPrice Channel Trading & Small Budget Trading Tips - earlytimes.in
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Will Larimar Therapeutics Inc. stock outperform value stocks2025 Market WrapUp & Weekly Top Gainers Trade List - BỘ NỘI VỤ
Published on: 2025-11-27 11:17:59 - BỘ NỘI VỤ
Published on: 2025-11-26 23:31:58 - BỘ NỘI VỤ
Larimar Therapeutics Advances Phase 1 Study on Nomlabofusp for Friedreich’s Ataxia - MSN
Should You Track Oswal Yarns Limited as a LongTerm Growth PlayTechnical Analysis Insights & Learn to Trade with Real-Time Feedback - earlytimes.in
Is Larimar Therapeutics Inc. stock a smart buy before Fed meetingForecast Cut & Daily Profit Focused Screening - newser.com
Larimar Therapeutics Highlights Promising Friedreich’s Ataxia Data - MSN
Why Larimar Therapeutics Inc. (ZA71) stock stays on top picksMarket Growth Review & Risk Controlled Swing Alerts - newser.com
Why Larimar Therapeutics Inc. stock is favored by pension fundsProfit Target & Verified Stock Trade Ideas - newser.com
Detecting price anomalies in Larimar Therapeutics Inc. with AIMarket Trend Report & Capital Efficiency Focused Strategies - newser.com
Multi factor analysis applied to Larimar Therapeutics Inc.Quarterly Market Summary & Safe Capital Allocation Plans - newser.com
Published on: 2025-11-19 03:24:17 - newser.com
Published on: 2025-11-19 01:23:45 - newser.com
Larimar Therapeutics Inc. stock retracement – recovery analysisJuly 2025 Macro Moves & Capital Protection Trading Alerts - newser.com
What machine learning models say about Larimar Therapeutics Inc.2025 Sector Review & Accurate Entry/Exit Alerts - newser.com
How moving averages guide Larimar Therapeutics Inc. tradingStock Surge & Verified Short-Term Plans - newser.com
What institutional flow reveals about Larimar Therapeutics Inc.Portfolio Return Summary & Real-Time Buy Signal Notifications - newser.com
Larimar Therapeutics, Inc.Common Stock (NQ: LRMR - Markets Financial Content
Will Larimar Therapeutics Inc. stock outperform Dow Jones indexInsider Buying & Free Verified High Yield Trade Plans - newser.com
Will Larimar Therapeutics Inc. stock gain from lower inflationCEO Change & Consistent Growth Equity Picks - newser.com
How Larimar Therapeutics Inc. stock trades during market volatilityJuly 2025 Gainers & Consistent Income Trade Ideas - newser.com
Will Larimar Therapeutics Inc. stock benefit from automationJuly 2025 Trade Ideas & Technical Entry and Exit Alerts - newser.com
Larimar Therapeutics Shows Promise in Friedreich’s Ataxia Treatment - MSN
Here's Why We're Watching Larimar Therapeutics' (NASDAQ:LRMR) Cash Burn Situation - Yahoo Finance
Finanzdaten der Larimar Therapeutics Inc-Aktie (LRMR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.10%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):